{"id":13638,"date":"2012-07-06T13:19:31","date_gmt":"2012-07-06T11:19:31","guid":{"rendered":"http:\/\/miunidad.eu\/porib.com\/?p=13638"},"modified":"2021-07-06T13:23:18","modified_gmt":"2021-07-06T11:23:18","slug":"oyaguez-i-cajaraville-g-del-campo-jm-carreras-mj-montalar-j-rubio-mj-garcia-san-andres-b-casado-ma","status":"publish","type":"post","link":"https:\/\/porib.com\/en\/oyaguez-i-cajaraville-g-del-campo-jm-carreras-mj-montalar-j-rubio-mj-garcia-san-andres-b-casado-ma\/","title":{"rendered":"Oyag\u00fcez I, Cajaraville G, del Campo JM, Carreras MJ, Montalar J, Rubio MJ, Garc\u00eda-San Andr\u00e9s B, Casado MA"},"content":{"rendered":"<div class=\"miniatura_foto\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-13495 alignleft\" src=\"https:\/\/porib.com\/wp-content\/uploads\/2021\/06\/pharmacoeconomics_spanish_research_articles-1.jpg\" alt=\"\" width=\"90\" height=\"120\" \/><\/div>\n<p><strong>Oyag\u00fcez I, Cajaraville G, del Campo JM, Carreras MJ, Montalar J, Rubio MJ, Garc\u00eda-San Andr\u00e9s B, Casado MA<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h6 style=\"text-align: justify;\">Impacto presupuestario de trabectedina y doxorubicina liposomal pegilada (DLP) para el tratamiento del c\u00e1ncer de ovario parcialmente sensible al platino<\/h6>\n<h6 style=\"text-align: justify;\"><strong>PharmacoEconomics Span Res Art. 2012;9(3):83-94<\/strong><\/h6>\n<div class=\"col80p\">\n<p style=\"text-align: justify;\"><a href=\"http:\/\/link.springer.com\/article\/10.1007\/BF03320878\" target=\"_blank\" rel=\"noopener\">M\u00c1S INFORMACI\u00d3N<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Oyag\u00fcez I, Cajaraville G, del Campo JM, Carreras MJ, Montalar J, Rubio MJ, Garc\u00eda-San Andr\u00e9s B, Casado MA &nbsp; &nbsp; Impacto presupuestario de trabectedina y doxorubicina liposomal pegilada (DLP) para el tratamiento del c\u00e1ncer de ovario parcialmente sensible al platino PharmacoEconomics Span Res Art. 2012;9(3):83-94 M\u00c1S INFORMACI\u00d3N<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"quote","meta":{"footnotes":""},"categories":[936,928,304],"tags":[],"class_list":["post-13638","post","type-post","status-publish","format-quote","hentry","category-aip-tipo-de-proyecto","category-oncologia","category-pharmacoeconomics-spanish-research-articles","post_format-post-format-quote"],"translation":{"provider":"WPGlobus","version":"2.10.3","language":"en","enabled_languages":["es","en"],"languages":{"es":{"title":true,"content":true,"excerpt":false},"en":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13638"}],"collection":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/comments?post=13638"}],"version-history":[{"count":1,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13638\/revisions"}],"predecessor-version":[{"id":13639,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13638\/revisions\/13639"}],"wp:attachment":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media?parent=13638"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/categories?post=13638"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/tags?post=13638"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}